Quetiapin Retard Sandoz 200 mg (quetiapine) · CNK 4251815

Product information

Quetiapin Retard Sandoz 200 mg
60
quetiapine
4251815
0 / 10
Locked

Product properties

111974-69-7
N05AH04
Sandoz
Prolonged-release tablet
BE483386
07613421045272
M1
Public
483386-05

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Commercial reasons) and no stock is available from wholesalers. Switching to an alternative is necessary.

Recommended alternative

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Commercial reasons

Alternative available

Composition

2 ingredients

Substance Type Strength CAS
Active ingredient
230.24 mg
111974-72-2
Excipient
56.84 mg

Additional information

View on BCPI

Availability statistics

Commercialization stopped
597 days
2
0
22/09/2025